4.3.4 Other antidepressant drugs
MHRA Safety Update (October 2012): Agomelatine: Risk of liver toxicity
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 capsule |
| Pack |
|---|
| 28 capsule |
| Pack |
|---|
| 30 tablet |
| Pack |
|---|
| 30 tablet |
| Pack |
|---|
| 30 tablet |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 capsule |
| Pack |
|---|
| 28 capsule |
Vortioxetine is recommended by NICE as an option for treating major depressive episodes in adults whose condition has responded inadequately to 2 antidepressants. There is no evidence that clearly demonstrates that vortioxetine is superior to other antidepressants in terms of clinical effectiveness.
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
- First Line Drugs
- Second Line Drugs
- Specialist Initiated or Recommended Drugs
- Specialist Initiated Drugs with Shared Care Guidelines
- Specialist Only Drugs
- Mixed Status